Edition:
United States

Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.86USD
17 Feb 2017
Change (% chg)

$-0.03 (-3.27%)
Prev Close
$0.89
Open
$0.91
Day's High
$0.91
Day's Low
$0.71
Volume
838,888
Avg. Vol
388,489
52-wk High
$3.52
52-wk Low
$0.50

ACUR.O

Chart for ACUR.O

About

Acura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The... (more)

Overall

Beta: 2.39
Market Cap(Mil.): $10.18
Shares Outstanding(Mil.): 11.83
Dividend: --
Yield (%): --

Financials

  ACUR.O Industry Sector
P/E (TTM): -- 47.80 29.39
EPS (TTM): -0.83 -- --
ROI: -105.56 -4.08 13.06
ROE: -238.90 4.84 14.19

BRIEF-Acura Pharmaceuticals files for secondary offering of up to $5.0 mln

* Files for secondary offering of up to $5.0 million - sec filing Source text for Eikon: Further company coverage:

Feb 03 2017

BRIEF-Acura Pharmaceuticals qtrly loss per share $0.19

* Acura Pharmaceuticals announces third quarter 2016 financial results

Nov 14 2016

BRIEF-KemPharm announces licensing agreement with Acura

* KemPharm announces licensing agreement with Acura Pharmaceuticals for aversion abuse-deterrent technology

Oct 18 2016

More From Around the Web

Earnings vs. Estimates